Science news

<<  return


MI-GENES: Discussing Genetic Risk for CHD May Motivate Patients to Lower LDL-C Levels

Informing intermediate-risk patients of their probability of developing CHD over the next decade based on their genomic risk may encourage them to improve health outcomes, suggests new research. The MI-GENES study showed that those who received their genetic-risk score, based on 28 genetic variants, plus discussion about traditional CHD risk factors, had significantly lower levels of LDL-C 6 months later vs those who heard about traditional risk factors only (the primary end point, P=0.04).The results of MI-GENES study were presented the  at the American Heart Association (AHA) 2015 Scientific Sessions.